Search

Type

Audience

Category

Issue

Last updated

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 2 of 2 items.

" " Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
… Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the … room (ER) physicians. Key messages On June 9, 2021, casirivimab and imdevimab, two monoclonal antibodies, were …
AlertHealth professional risk communication | 2021-07-30
" " Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
… Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation … risk communication See Key Messages below 2022-01-07 Casirivimab and Imdevimab There is a high risk of treatment failure with the …
AlertHealth professional risk communication | 2022-01-07
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.